KENNEDY CAPITAL MANAGEMENT LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 58 filers reported holding CTI BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$742,598
-30.0%
176,809
+0.1%
0.02%
-26.7%
Q4 2022$1,061,192
+3.2%
176,571
-0.1%
0.03%0.0%
Q3 2022$1,028,000
-65.6%
176,706
-64.7%
0.03%
-64.3%
Q2 2022$2,988,000
+1.0%
500,434
-21.0%
0.08%
+20.0%
Q1 2022$2,957,000
+63.7%
633,259
-13.1%
0.07%
+84.2%
Q4 2021$1,806,000
+21.4%
728,395
+44.4%
0.04%
+15.2%
Q3 2021$1,488,000
+6663.6%
504,382
+4943.8%
0.03%
+3200.0%
Q3 2020$22,000
-98.9%
10,000
-97.5%
0.00%
-97.3%
Q2 2018$1,965,000
+25.5%
394,505
-1.8%
0.04%
+23.3%
Q1 2018$1,566,000
+137.3%
401,628
+63.1%
0.03%
+150.0%
Q4 2017$660,000246,1890.01%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2021.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders